Igor Slukvin - Publications

Affiliations: 
Cellular & Molecular Pathology University of Wisconsin, Madison, Madison, WI 
Area:
Cell Biology, Medicine and Surgery

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mesquitta WT, Wandsnider M, Kang H, Thomson J, Moskvin O, Suknuntha K, Slukvin II. UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells. Scientific Reports. 9: 6622. PMID 31036928 DOI: 10.1038/s41598-019-43054-4  0.52
2018 Kumar A, Lee JH, Suknuntha K, D'Souza SS, Thakur AS, Slukvin II. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 30578305 DOI: 10.4049/jimmunol.1801027  0.52
2018 Slukvin II, Kumar A. The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells. Cellular and Molecular Life Sciences : Cmls. PMID 29992471 DOI: 10.1007/s00018-018-2871-3  0.32
2018 Park MA, Kumar A, Jung HS, Uenishi G, Moskvin OV, Thomson JA, Slukvin II. Activation of the Arterial Program Drives Development of Definitive Hemogenic Endothelium with Lymphoid Potential. Cell Reports. 23: 2467-2481. PMID 29791856 DOI: 10.1016/j.celrep.2018.04.092  0.32
2018 Uenishi GI, Jung HS, Kumar A, Park MA, Hadland BK, McLeod E, Raymond M, Moskvin O, Zimmerman CE, Theisen DJ, Swanson S, J Tamplin O, Zon LI, Thomson JA, Bernstein ID, ... Slukvin II, et al. NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nature Communications. 9: 1828. PMID 29739946 DOI: 10.1038/s41467-018-04134-7  0.32
2018 D'Souza SS, Kumar A, Slukvin II. Functional Heterogeneity of Endothelial Cells Derived from Human Pluripotent Stem Cells. Stem Cells and Development. PMID 29583085 DOI: 10.1089/scd.2017.0238  0.32
2018 Suknuntha K, Tao L, Brok-Volchanskaya V, D'Souza SS, Kumar A, Slukvin I. Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells. Stem Cell Reviews. PMID 29520567 DOI: 10.1007/s12015-018-9805-1  0.52
2017 Kumar A, D'Souza SS, Moskvin OV, Toh H, Wang B, Zhang J, Swanson S, Guo LW, Thomson JA, Slukvin II. Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts. Cell Reports. 19: 1902-1916. PMID 28564607 DOI: 10.1016/j.celrep.2017.05.019  0.32
2016 Jung HS, Uenishi G, Kumar A, Park MA, Raymond M, Fink D, McLeod E, Slukvin I. A human VE-cadherin-tdTomato and CD43-green fluorescent protein dual reporter cell line for study endothelial to hematopoietic transition. Stem Cell Research. 17: 401-405. PMID 27879215 DOI: 10.1016/j.scr.2016.09.004  0.32
2016 Suknuntha K, Thita T, Togarrati PP, Ratanachamnong P, Wongtrakoongate P, Srihirun S, Slukvin I, Hongeng S. Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines. International Journal of Hematology. PMID 27766528 DOI: 10.1007/s12185-016-2116-x  0.52
2016 Hafner AL, Contet J, Ravaud C, Yao X, Villageois P, Suknuntha K, Annab K, Peraldi P, Binetruy B, Slukvin II, Ladoux A, Dani C. Brown-like adipose progenitors derived from human induced pluripotent stem cells: Identification of critical pathways governing their adipogenic capacity. Scientific Reports. 6: 32490. PMID 27577850 DOI: 10.1038/srep32490  0.36
2016 D'Souza SS, Maufort J, Kumar A, Zhang J, Smuga-Otto K, Thomson JA, Slukvin II. GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells. Stem Cell Reports. PMID 26805448 DOI: 10.1016/j.stemcr.2015.12.010  0.36
2015 Elcheva I, Brok-Volchanskaya V, Slukvin I. Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells. Journal of Visualized Experiments : Jove. e52910. PMID 26710184 DOI: 10.3791/52910  0.32
2015 Suknuntha K, Ishii Y, Tao L, Hu K, McIntosh BE, Yang D, Swanson S, Stewart R, Wang JY, Thomson J, Slukvin I. Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells. Stem Cell Research. 15: 678-693. PMID 26561938 DOI: 10.1016/j.scr.2015.10.015  0.36
2015 McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, Thomson JA. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Reports. 4: 171-80. PMID 25601207 DOI: 10.1016/j.stemcr.2014.12.005  0.36
2014 Uenishi G, Theisen D, Lee JH, Kumar A, Raymond M, Vodyanik M, Swanson S, Stewart R, Thomson J, Slukvin I. Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports. 3: 1073-84. PMID 25448067 DOI: 10.1016/j.stemcr.2014.09.014  0.36
2014 Elcheva I, Brok-Volchanskaya V, Kumar A, Liu P, Lee JH, Tong L, Vodyanik M, Swanson S, Stewart R, Kyba M, Yakubov E, Cooke J, Thomson JA, Slukvin I. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nature Communications. 5: 4372. PMID 25019369 DOI: 10.1038/ncomms5372  0.36
2013 Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, Yang H, Wang T, Lee AY, Swanson SA, Zhang J, ... ... Slukvin I, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 153: 1134-48. PMID 23664764 DOI: 10.1016/j.cell.2013.04.022  0.36
2013 Hu K, Slukvin I. Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors. Methods in Molecular Biology (Clifton, N.J.). 997: 163-76. PMID 23546755 DOI: 10.1007/978-1-62703-348-0_13  0.36
2012 Choi KD, Vodyanik MA, Togarrati PP, Suknuntha K, Kumar A, Samarjeet F, Probasco MD, Tian S, Stewart R, Thomson JA, Slukvin II. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Reports. 2: 553-67. PMID 22981233 DOI: 10.1016/j.celrep.2012.08.002  0.36
2011 Dias J, Gumenyuk M, Kang H, Vodyanik M, Yu J, Thomson JA, Slukvin II. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells and Development. 20: 1639-47. PMID 21434814 DOI: 10.1089/scd.2011.0078  0.36
2011 Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 117: e109-19. PMID 21296996 DOI: 10.1182/blood-2010-07-298331  0.36
2010 Vodyanik MA, Yu J, Zhang X, Tian S, Stewart R, Thomson JA, Slukvin II. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell. 7: 718-29. PMID 21112566 DOI: 10.1016/j.stem.2010.11.011  0.36
2010 Berahovich RD, Zabel BA, Penfold ME, Lewén S, Wang Y, Miao Z, Gan L, Pereda J, Dias J, Slukvin II, McGrath KE, Jaen JC, Schall TJ. CXCR7 protein is not expressed on human or mouse leukocytes. Journal of Immunology (Baltimore, Md. : 1950). 185: 5130-9. PMID 20889540 DOI: 10.4049/jimmunol.1001660  0.36
2009 Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York, N.Y.). 324: 797-801. PMID 19325077 DOI: 10.1126/science.1172482  0.36
2009 Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, Thomson J, Slukvin I. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 27: 559-67. PMID 19259936 DOI: 10.1634/stemcells.2008-0922  0.36
2008 Salvagiotto G, Zhao Y, Vodyanik M, Ruotti V, Stewart R, Marra M, Thomson J, Eaves C, Slukvin I. Molecular profiling reveals similarities and differences between primitive subsets of hematopoietic cells generated in vitro from human embryonic stem cells and in vivo during embryogenesis Experimental Hematology. 36: 1377-1389. PMID 18922365 DOI: 10.1016/j.exphem.2008.06.015  0.36
2008 Metallo CM, Vodyanik MA, de Pablo JJ, Slukvin II, Palecek SP. The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnology and Bioengineering. 100: 830-7. PMID 18306423 DOI: 10.1002/bit.21809  0.36
2007 Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science (New York, N.Y.). 318: 1917-20. PMID 18029452 DOI: 10.1126/science.1151526  0.36
2007 Rajesh D, Chinnasamy N, Mitalipov SM, Wolf DP, Slukvin I, Thomson JA, Shaaban AF. Differential requirements for hematopoietic commitment between human and rhesus embryonic stem cells. Stem Cells (Dayton, Ohio). 25: 490-9. PMID 17284653 DOI: 10.1634/stemcells.2006-0277  0.36
2006 Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 108: 2095-105. PMID 16757688 DOI: 10.1182/blood-2006-02-003327  0.36
2006 Holla P, Hafez GR, Slukvin I, Kalayoglu M. Synovial sarcoma, a primary liver tumor--a case report. Pathology, Research and Practice. 202: 385-7. PMID 16503097 DOI: 10.1016/j.prp.2005.12.006  0.36
Show low-probability matches.